These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6300912)

  • 21. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
    Bolger GT; Marcus KA; Daly JW; Skolnick P
    J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle.
    Valdivia HH; Coronado R
    J Gen Physiol; 1990 Jan; 95(1):1-27. PubMed ID: 2153750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
    Ferry DR; Goll A; Glossmann H
    Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional distribution of calcium channel ligand (1,4-dihydropyridine) binding sites and 45Ca2+ uptake processes in rat brain.
    Skattebøl A; Triggle DJ
    Biochem Pharmacol; 1987 Dec; 36(23):4163-6. PubMed ID: 2446630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties.
    Knaus HG; Striessnig J; Hering S; Marrer S; Schwenner E; Höltje HD; Glossmann H
    Mol Pharmacol; 1992 Feb; 41(2):298-307. PubMed ID: 1311409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of multiple receptor sites within the putative calcium channel.
    Ferry DR; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries.
    Yamada S; Uchida S; Naito T; Urayama A; Kimura R; Murakami Y; Matsumoto K; Watanabe H
    Life Sci; 2000 Feb; 66(14):1351-7. PubMed ID: 10755471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dihydropyridines on calcium release from the isolated membrane complex consisting of the transverse tubule and sarcoplasmic reticulum.
    Ohkusa T; Carlos AD; Kang JJ; Smilowitz H; Ikemoto N
    Biochem Biophys Res Commun; 1991 Feb; 175(1):271-6. PubMed ID: 1847807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of salt loading and nitrendipine on dihydropyridine receptors in hypertensive rats.
    Garthoff B; Bellemann P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S36-9. PubMed ID: 2455136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro binding of [3H]nimodipine and [3H]CGS-19755 to rat brain in focal cerebral ischemia.
    Hogan MJ; Takizawa S; Hakim AM
    Exp Neurol; 1995 Jul; 134(1):56-63. PubMed ID: 7672038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists.
    Uchida S; Yamada S; Nagai K; Deguchi Y; Kimura R
    Life Sci; 1997; 61(21):2083-90. PubMed ID: 9395249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of binding affinities and negative inotropic potencies of the 1,4-dihydropyridine calcium channel blockers in rabbit myocardium.
    Boyd RA; Giacomini JC; Wong FM; Nelson WL; Giacomini KM
    J Pharmacol Exp Ther; 1987 Oct; 243(1):118-25. PubMed ID: 2822893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of dihydropyridine (DHP) binding sites on cultured monkey renal cells (GMRC) with a photoaffinity probe (-)-[3H]-azidopine.
    Drímal J
    Gen Physiol Biophys; 1994 Apr; 13(2):137-48. PubMed ID: 7528701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.
    Herbette LG; Vant Erve YM; Rhodes DG
    J Mol Cell Cardiol; 1989 Feb; 21(2):187-201. PubMed ID: 2545886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo binding of nimodipine in the brain: II. Binding kinetics in focal cerebral ischemia.
    Hogan MJ; Gjedde A; Hakim AM
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):771-8. PubMed ID: 1874809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine binding sites and their localization in the central nervous system.
    Martin BR; Aceto MD
    Neurosci Biobehav Rev; 1981; 5(4):473-8. PubMed ID: 7033844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-affinity antibodies to the 1,4-dihydropyridine Ca2+-channel blockers.
    Campbell KP; Sharp A; Strom M; Kahl SD
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2792-6. PubMed ID: 3010317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
    Enyeart JJ; Aizawa T; Hinkle PM
    Am J Physiol; 1985 May; 248(5 Pt 1):C510-9. PubMed ID: 3922229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.